Evaluation of an immunotherapeutic DNA-vaccine in biochemically relapsed prostate cancer.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Neal D. Shore, Elisabeth I. Heath, Luke T. Nordquist, Heather H. Cheng, Kamalnayan Bhatt, Matthew Morrow, Trevor McMullan, Kimberly Kraynyak, Jessica Lee, Brian Sacchetta, Li Liu, Samantha Rosencranz, Scott T. Tagawa, Rahul Atul Parikh, Ronald F Tutrone, Jorge A. Garcia, Young E. Whang, William Kevin Kelly, Ildiko Csiki, Mark L. Bagarazzi
Institutions: Carolina Urologic Research Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Urology Cancer Center and GU Research Network, University of Washington, Inovio Pharmaceuticals (United States), University of Kansas, Chesapeake Urology Associates, Cleveland Clinic, University of North Carolina at Chapel Hill, Thomas Jefferson University, Sidney Kimmel Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889993438